• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Biocon Limited — Important, 12-01-2026: Updates

    12-01-2026 | 08:40 am

    Biocon's subsidiary gained approval for its Everolimus Tablets for Oral Suspension (2, 3, 5 mg), indicated for Tuberous Sclerosis Complex conditions. This development strengthens Biocon's vertically integrated drug product portfolio.

    No comments yet. Be the first to comment!

    All announcements from Biocon Limited